Targeting pancreatic ductal adenocarcinoma: New therapeutic options for the ongoing battle

• 作者: Pratibha Malhotra Ranjith Palanisamy Marco Falasca
• 来源期刊: 国际肝胆胰疾病杂志（英文版）
• 年，卷（期）: 2022,（1）
• 所属期刊栏目: EDITORIALS
• 页码范围: 4-6
• 页数: 3页
• 语种: 英文

摘要

Pancreatic ductal adenocarcinoma (PDAC), the most commonly reported form of pancreatic cancer, is a lethal malignancy that con- tributes to the global cancer burden with high morbidity and mor- tality [1] . It has a poor 5-year survival mainly because PDAC poses a significant diagnostic challenge, has a high metastatic rate at di- agnosis and is stubbornly resistant to therapy [2] .